Postnatal placental confirmation of trisomy 2 and trisomy 16 detected at chorionic villus sampling: A possible association with intrauterine growth retardation and elevated maternal serum alpha-fetoprotein

1992 ◽  
Vol 12 (3) ◽  
pp. 157-162 ◽  
Author(s):  
J. S. Fryburg ◽  
M. S. Dimaio ◽  
M. J. Mahoney
1991 ◽  
Vol 32 (4) ◽  
pp. 292 ◽  
Author(s):  
Young Ho Yang ◽  
Meong Sun Lee ◽  
Yong Won Park ◽  
Sei Kwang Kim ◽  
Hae Ree Sung ◽  
...  

1997 ◽  
Vol 17 (10) ◽  
pp. 953-959 ◽  
Author(s):  
Mieke W. J. C. Jansen ◽  
Helen Brandenburg ◽  
Hajo I. J. Wildschut ◽  
Anton C. M. Martens ◽  
Adriana M. Hagenaars ◽  
...  

2014 ◽  
Vol 40 (6) ◽  
pp. 1540-1546 ◽  
Author(s):  
A. Seval Ozgu-Erdinc ◽  
Sabri Cavkaytar ◽  
Ayla Aktulay ◽  
Umran Buyukkagnici ◽  
Salim Erkaya ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Takol Chareonsirisuthigul ◽  
Suchin Worawichawong ◽  
Rachanee Parinayok ◽  
Patama Promsonthi ◽  
Budsaba Rerkamnuaychoke

Fetal trisomy 16 is considered uniformly lethal early in gestation. It has been reported to be associated with the variability of clinical features and outcomes. Mosaic trisomy 16 leads to a high risk of abnormality in prenatal cases. Intrauterine growth retardation (IUGR) is a common outcome of mosaic trisomy 16. Herein, we report on the case of Thai male IUGR fetus with trisomy 16 mosaicism. The fetal body was too small. Postmortem investigation of placenta revealed the abnormality including small placenta with furcated cord insertion and single umbilical cord artery. Cytogenetic study demonstrated trisomy 16 that was found 100% in placenta and only 16% in the fetal heart while other organs had normal karyotype. In addition, cardiac and other internal organs examination revealed normal morphology.


PEDIATRICS ◽  
1986 ◽  
Vol 77 (4) ◽  
pp. 582-586
Author(s):  
Barbara K. Burton ◽  
Robert G. Dillard

The outcome in infants without fetal neural tube defect born to mothers with elevated maternal serum α-fetoprotein was studied. Elevated maternal serum α-fetoprotein with normal amniotic fluid α-fetoprotein was found to be associated with an increased incidence of intrauterine growth retardation and nonneural tube congenital anomalies. There was no increased incidence of developmental disabilities in infants born to mothers with elevated maternal serum α-fetoprotein. It is speculated that adverse events occurring early in gestation may simultaneously result in congenital anomalies and subsequently elevated maternal serum α-fetoprotein, perhaps through disruption of the normal placental barrier between the fetal and maternal circulations.


Sign in / Sign up

Export Citation Format

Share Document